CompaniesRodin Therapeutics

Rodin Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

18

By Phase

PHASE1: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
2029
2030
Today
NCT06834282
Hover over trial bars to see details

Recent Trials

NCT06834282Lead Sponsor
CER-1236 in Patients With Acute Myeloid Leukemia (AML)
PHASE1Recruiting
18 participants
Started: Apr 7, 2025 · Completed: Dec 31, 2029
Funding History (1)
D
Sep 14, 2017
Filing
Related Companies
Alkermes
acquired